Nrf2-mediated macrophage function in benign prostatic hyperplasia: Novel molecular insights and implications

Guanhui Song1, Jinlin Tong2, Yuhe Wang2

  • 1The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China.

Summary

Benign prostatic hyperplasia (BPH) involves inflammation and oxidative stress. The nuclear factor erythroid2-related factor 2 (Nrf2) pathway may offer a treatment strategy by modulating macrophage activation and the immune microenvironment.